Asylum Ventures | Activity | F4Asylum Ventures Activity
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Investment
Participated in Henlo's $3M Seed round alongside Framework Ventures, SNZ Capital, and Primitive Ventures.
Henlo
Participated in Nucleus Genomics' $14M Series A for whole-genome sequencing and genetic risk assessment.
Essay
Published founding letter arguing that the best founders are artists and outlining Asylum's philosophy of founder-first, no-board-seat investing.
Founding Letter — The best founders are artists
Press
Nicholas Chirls featured in New York Times piece on pushback against industrialization of venture capital.
Nicholas Chirls on Asylum Ventures founding in The New York Times
New Fund
Closed debut Fund I with $55M to back early-stage founders as artists building novel companies.
Fund I — $55M